CPHI vs MA · rev $4.5M vs P/E 38, rev $32.79B
China Pharma Holdings Inc (CPHI) versus Mastercard Inc (MA) — a side-by-side from cached financials, not a winner call.
China Pharma Holdings Inc (CPHI) is a drug manufacturers - specialty & generic company listed on US.
Mastercard Inc (MA) is a credit services company listed on US. It is led by Michael Miebach.
Latest reported CPHI revenue for 2024-12-31 was $4.5M. Net income was -$4.7M. Revenue was down 35.4% from 2023-12-31 to 2024-12-31. CPHI currently screens at market cap $29.0M.
Latest reported MA revenue for 2025-12-31 was $32.79B. Net income was $14.97B. Revenue was up 16.4% from 2024-12-31 to 2025-12-31. MA currently screens at market cap $515.12B and trailing P/E 38.4.
CPHI currently screens at market cap $29.0M. MA currently screens at market cap $515.12B and trailing P/E 38.4.
Not investment advice. Open the CPHI and MA stock pages for the full models.
Not investment advice.